PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
smallcap2
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


SLNO 14.29%ALAR 14.29%ROOT 14.29%SWVL 14.29%CVNA 14.29%ZJYL 14.29%LABP 14.29%EquityEquity
PositionCategory/SectorTarget Weight
ALAR
Alarum Technologies Ltd.
Technology
14.29%
CVNA
Carvana Co.
Consumer Cyclical
14.29%
LABP
Landos Biopharma, Inc.
Healthcare
14.29%
ROOT
Root, Inc.
Financial Services
14.29%
SLNO
Soleno Therapeutics, Inc.
Healthcare
14.29%
SWVL
Swvl Holdings Corp
Technology
14.29%
ZJYL
Jin Medical International Ltd
Healthcare
14.29%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in smallcap2, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


0.00%500.00%1,000.00%1,500.00%AugustSeptemberOctoberNovemberDecember2025
1,242.75%
53.63%
smallcap2
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Mar 28, 2023, corresponding to the inception date of ZJYL

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
3.73%1.05%11.76%24.74%13.51%11.82%
smallcap28.62%5.06%0.03%52.97%N/AN/A
SLNO
Soleno Therapeutics, Inc.
6.92%7.23%-0.87%3.13%-0.59%-6.25%
ALAR
Alarum Technologies Ltd.
-7.63%-14.78%-65.25%-6.84%-16.38%N/A
ROOT
Root, Inc.
14.78%14.14%22.80%851.14%N/AN/A
SWVL
Swvl Holdings Corp
-26.52%-27.85%-30.62%19.64%N/AN/A
CVNA
Carvana Co.
18.25%11.80%81.01%475.29%23.29%N/A
ZJYL
Jin Medical International Ltd
14.40%-15.24%-72.01%-90.00%N/AN/A
LABP
Landos Biopharma, Inc.
0.00%0.00%0.00%397.40%N/AN/A
*Annualized

Monthly Returns

The table below presents the monthly returns of smallcap2, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202412.19%-3.35%17.96%10.23%-4.10%3.87%-2.19%-11.10%-2.08%24.45%8.31%-18.26%31.78%
20236.91%0.50%28.52%33.93%28.98%4.92%60.59%-23.85%28.36%138.81%838.10%

Expense Ratio

smallcap2 has an expense ratio of 0.00%, indicating no management fees are charged. Below you can find the expense ratios of portfolio funds side-by-side and effortlessly compare their relative costs.


The portfolio doesn't hold funds that charge fees

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of smallcap2 is 16, meaning it’s performing worse than 84% of other portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of smallcap2 is 1616
Overall Rank
The Sharpe Ratio Rank of smallcap2 is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of smallcap2 is 1313
Sortino Ratio Rank
The Omega Ratio Rank of smallcap2 is 1515
Omega Ratio Rank
The Calmar Ratio Rank of smallcap2 is 2828
Calmar Ratio Rank
The Martin Ratio Rank of smallcap2 is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for smallcap2, currently valued at 0.98, compared to the broader market-1.000.001.002.003.004.005.000.981.98
The chart of Sortino ratio for smallcap2, currently valued at 1.57, compared to the broader market0.002.004.006.001.572.64
The chart of Omega ratio for smallcap2, currently valued at 1.21, compared to the broader market0.801.001.201.401.601.801.211.36
The chart of Calmar ratio for smallcap2, currently valued at 1.91, compared to the broader market0.002.004.006.008.0010.0012.001.913.00
The chart of Martin ratio for smallcap2, currently valued at 4.01, compared to the broader market0.0010.0020.0030.0040.004.0112.30
smallcap2
^GSPC

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
SLNO
Soleno Therapeutics, Inc.
-0.000.431.05-0.00-0.00
ALAR
Alarum Technologies Ltd.
0.020.991.110.040.06
ROOT
Root, Inc.
6.265.181.6514.5425.70
SWVL
Swvl Holdings Corp
0.081.311.190.140.21
CVNA
Carvana Co.
5.465.241.6413.3544.29
ZJYL
Jin Medical International Ltd
-0.56-0.880.90-0.94-1.15
LABP
Landos Biopharma, Inc.
2.1221.607.2754.70396.89

The current smallcap2 Sharpe ratio is 0.98. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 1.42 to 2.14, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests that it may not be performing as well in terms of risk-adjusted returns compared to many other portfolios. The lower performance could be due to either lower returns, higher volatility, or a combination of both. This might indicate that the portfolio requires some fine-tuning. You can use the Portfolio Optimization tool to find an allocation that maximizes the Sharpe ratio.

Use the chart below to compare the Sharpe ratio of smallcap2 with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.00AugustSeptemberOctoberNovemberDecember2025
0.98
1.98
smallcap2
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield


smallcap2 doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-15.97%
-0.29%
smallcap2
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the smallcap2. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the smallcap2 was 28.27%, occurring on Sep 10, 2024. Recovery took 43 trading sessions.

The current smallcap2 drawdown is 15.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-28.27%Jul 17, 202439Sep 10, 202443Nov 8, 202482
-26.6%Jan 3, 20244Jan 8, 202411Jan 24, 202415
-25.37%Oct 2, 202320Oct 27, 202324Dec 1, 202344
-24.47%Nov 25, 202431Jan 10, 2025
-22.64%Jul 20, 202321Aug 17, 202327Sep 26, 202348

Volatility

Volatility Chart

The current smallcap2 volatility is 10.55%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
10.55%
4.02%
smallcap2
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

LABPZJYLSWVLALARSLNOROOTCVNA
LABP1.000.100.02-0.050.070.030.02
ZJYL0.101.000.010.050.09-0.070.05
SWVL0.020.011.000.090.020.110.12
ALAR-0.050.050.091.000.110.080.14
SLNO0.070.090.020.111.000.100.25
ROOT0.03-0.070.110.080.101.000.40
CVNA0.020.050.120.140.250.401.00
The correlation results are calculated based on daily price changes starting from Mar 29, 2023
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab